NASDAQ$CHRS

Coherus Biosciences Inc · Q2 2018 earnings

Q2 2018 earnings · · Investor relations

Headline financials

Total Revenue

$1.4M

Previous: $1.4M+0.0%
EPS (adj)

-$0.68

Previous: -$1.08+37.0%
Capital Expenditures

-$86K

No prior period
Free Cash Flow

-$43.7M

No prior period
Net Income

-$43.6M

No prior period
Operating Income

-$44.9M

No prior period
Cash & Equivalents

$130M

No prior period
Total Assets

$188M

No prior period
Stock-Based Comp

$8.69M

No prior period

Revenue & EPS history

Coherus · Revenue · Quarterly

$1.4M

Q2 2018+0%vs Q2 2017
Beat estimate in 3 of 9 quarters(33%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2018

Historical avgQ2 2018

+0.3%

Avg return

Earnings day

-2.2%

Avg return

5 days after

+0.4%

Avg return

30 days after

53%

23 / 43 earnings

Positive

+28.8%

Q4 2017

Best reaction

-31.6%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+10.9%-10.3%
Q4 2025+1.6%-15.5%-14.5%
Q3 2025-9.6%-8.7%-19.5%
Q1 2025-18.7%-25.4%-22.5%
Q4 2024+1.0%-11.5%-28.7%
Q3 2024+12.2%+6.6%+132.6%
Q2 2024+15.3%+16.1%+0.0%
Q1 2024-14.8%-6.7%-24.2%
Q4 2023-3.1%-0.9%-0.4%
Q3 2023-31.6%-56.0%-36.6%
Q2 2023+13.8%+11.8%+21.4%
Q1 2023-19.9%-33.6%-27.1%
Q4 2022+3.4%-14.0%+8.8%
Q3 2022-10.4%-0.4%-12.7%
Q2 2022+17.6%+9.9%+1.4%
Q1 2022-13.3%-12.3%-22.1%
Q4 2021-6.5%-15.6%+1.0%
Q3 2021+4.9%+4.5%+1.9%
Q2 2021+1.8%+3.2%+22.8%
Q1 2021-1.6%-3.2%-8.8%
Q4 2020-6.1%-1.4%-10.5%
Q3 2020-7.6%+2.3%+4.9%
Q2 2020+8.0%+3.2%+1.4%
Q1 2020+6.9%+4.9%+16.2%
Q4 2019-5.1%-4.0%-20.2%
Q3 2019+16.4%+15.1%+11.1%
Q2 2019+19.0%+15.2%+31.9%
Q1 2019+8.4%+4.7%+11.1%
Q4 2018+2.4%+2.6%-2.8%
Q3 2018-19.4%-10.7%-16.3%
Q2 2018+2.5%+2.5%+2.7%
Q1 2018+5.8%+4.5%+1.8%
Q4 2017+28.8%+35.3%+23.9%
Q3 2017-6.9%-15.9%-29.7%
Q2 2017+6.3%-8.3%+13.4%
Q1 2017-1.5%+13.2%+4.6%
Q4 2016-5.4%-0.9%-19.6%
Q3 2016+15.7%+16.1%+16.6%
Q2 2016-3.3%-1.8%+1.8%
Q1 2016-6.3%
Q4 2015+4.1%
Q3 2015+0.5%
Q3 2014-3.5%
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro